Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.

ABSTRACT:

SUBMITTER: Lorentino F 

PROVIDER: S-EPMC9131907 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature